Eupraxia Pharmaceuticals Inc (EPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,500 | 80,564 | 88,959 | 19,766 | 27,455 |
| Marketable Securities | 80,379 | N/A | N/A | N/A | N/A |
| Receivables | 663 | 674 | 140 | 135 | 239 |
| TOTAL | $142,125 | $85,099 | $91,400 | $22,830 | $28,606 |
| Non-Current Assets | |||||
| PPE Net | 1,162 | 834 | 683 | 656 | 497 |
| Other Non-Current Assets | 2,067 | 217 | 266 | 111 | 130 |
| TOTAL | $3,228 | $1,052 | $949 | $766 | $627 |
| Total Assets | $145,353 | $86,150 | $92,349 | $23,596 | $29,233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,159 | 5,550 | 3,735 | 2,583 | 2,147 |
| TOTAL | $7,362 | $5,628 | $3,811 | $2,618 | $2,200 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1 | 10 | 8 | 7 | 5 |
| TOTAL | $1,803 | $76 | $95 | $N/A | $N/A |
| Total Liabilities | $9,166 | $5,704 | $3,906 | $2,618 | $2,200 |
| Shareholders' Equity | |||||
| Common Shares | 255,497 | 195,407 | 191,017 | 117,117 | 116,840 |
| Retained earnings | -182,233 | -169,580 | -152,869 | -146,507 | -137,766 |
| Other shareholders' equity | -6,080 | -3,639 | -4,881 | -4,365 | -5,693 |
| TOTAL | $136,188 | $80,446 | $88,444 | $20,978 | $27,033 |
| Total Liabilities And Equity | $145,353 | $86,150 | $92,349 | $23,596 | $29,233 |